You are viewing: Vietnam Plasma Fractionation Market analysis
Part of: Plasma Fractionation Market (Global)

The Vietnam Plasma Fractionation Market was valued at $39.5 Million in 2026 and projected to reach to $49.5 Million by 2031, representing a compound annual growth rate of 4.6%. Vietnam's plasma fractionation market is positioned for steady growth as the country's healthcare system modernizes and expands access to advanced biopharmaceutical therapies.

Vietnam Plasma Fractionation Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Vietnam Plasma Fractionation Market Trends and Insights

  • Vietnam's healthcare sector is increasingly investing in advanced therapeutic solutions, driving demand for plasma-derived products including immunoglobulins, clotting factors, and albumin.
  • The market expansion in Vietnam reflects rising awareness of rare bleeding disorders, immunodeficiency conditions, and improved access to specialty pharmaceuticals across urban and emerging healthcare centers. Vietnam's plasma fractionation market growth is supported by strengthening healthcare infrastructure, government initiatives to enhance blood safety standards, and growing patient populations requiring plasma-derived therapies.
  • Between 2026 and 2031, Vietnam is expected to see increased adoption of plasma fractionation products as healthcare providers expand treatment capabilities.
  • The market dynamics in Vietnam are shaped by regulatory improvements, rising healthcare expenditure, and partnerships with international plasma manufacturers seeking to establish regional distribution networks..

Key Market Statistics

  • CAGR (2026-2031) 4.6% CAGR
  • Market Size, 2026 ~USD 39.5 Million
  • Forecast, 2031 ~USD 49.5 Million
  • Country Vietnam

Vietnam Plasma Fractionation Market Overview

Market Size & Growth :

Vietnam's plasma fractionation market is valued at USD 39.5 million in 2026 and is projected to reach USD 49.5 million by 2031, with a CAGR of 4.6%, outpacing many regional peers in Southeast Asia.

Healthcare Investment Surge :

Vietnam's healthcare sector is experiencing rapid modernization with increased government funding and private sector investment in advanced therapeutic solutions, creating favorable conditions for plasma-derived product adoption.

Product Demand Drivers :

Rising demand for immunoglobulins, clotting factors, and albumin is driven by growing prevalence of immunodeficiency disorders, bleeding disorders, and critical care needs in Vietnam's expanding patient population.

Regulatory & Infrastructure Development :

Vietnam's strengthening regulatory framework and improving cold chain infrastructure are facilitating market entry and distribution of plasma fractionation products across urban and emerging healthcare facilities.

Vietnam Plasma Fractionation Market Dynamics

  • Increasing awareness of plasma-derived treatments among healthcare professionals and patients, coupled with rising disposable incomes, will drive market expansion through 2031.
  • Government initiatives to strengthen blood safety standards and plasma collection infrastructure are creating opportunities for market players to establish sustainable operations. The market will benefit from Vietnam's aging population and rising prevalence of chronic diseases requiring plasma-derived interventions.
  • Strategic partnerships between international manufacturers and local distributors, along with investments in manufacturing capabilities, will accelerate market penetration.
  • However, competition from biosimilars and cost-containment pressures in the healthcare system may moderate growth rates compared to global benchmarks..

Market Ecosystem

logo-mobile

PLASMA FRACTIONATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Implemented the Horizon 2 plasma fractionation process at its Kankakee facility to improve immunoglobulin recovery from donated plasma Higher immunoglobulin yield | Improved plasma utilization | Greater production efficiency | Increased supply capacity
company logo
Implemented process improvements through its One Day Batch Release program at plasma-derived therapy manufacturing sites to accelerate batch release Faster batch release | Improved manufacturing efficiency | Shorter lead times | Faster product availability

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • SANOFI
    • Pfizer Inc.
    • NOVARTIS

      Key Takeaways

      • Vietnam's plasma fractionation market is valued at USD 39.5 million in 2026 and will reach USD 49.5 million by 2031 at a 4.6% CAGR.
      • Vietnam is experiencing increased demand for immunoglobulins and clotting factors driven by rising awareness of rare bleeding and immunodeficiency disorders.
      • Healthcare infrastructure improvements and government blood safety initiatives are key growth catalysts for Vietnam's plasma fractionation sector.
      • Vietnam presents opportunities for international plasma manufacturers to establish regional distribution and manufacturing partnerships through 2031.

      Plasma Fractionation Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment SCIG (Type)
      Forecast Period 2026-2030
      Growth Rate CAGR of 7.6% from 2026 to 2030
      Largest Segment THERAPEUTICS (Application)
      Market Size Base Year (Billions) ~USD 36.46 (2026)
      Revenue Forecast (Billions) ~USD 48.87 (2030)
      Segments Covered Product, Type, Application, Therapeutic Area, End User

      Vietnam Plasma Fractionation Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Albumin
      • Coagulation Factor Concentrates
      • Immunoglobulins
      • Other Plasma Products
      • Protease Inhibitors

      By Type

      • Factor Ix
      • Factor Viii
      • Factor Xiii
      • Fibrinogen Concentrates
      • Ivig
      • Other Coagulation
      • Other Coagulation Factor Concentrates
      • Other Immunoglobulins
      • Prothrombin Complex Concentrates
      • Prothrombin Factor Concentrates
      • Scig
      • Von Willebrand Factor

      By Application

      • Academics & Preclinical Research
      • Therapeutics

      By Therapeutic Area

      • Critical Care
      • Hemato-Oncology
      • Hematology
      • Immunology
      • Neurology
      • Other Therapeutic Areas
      • Pulmonology
      • Rheumatology

      By End User

      • Home Care Settings & Infusion Centers
      • Hospitals & Specialty Clinics
      • Other End Users

      Target Audience

      • Pharmaceutical Manufacturers : Plasma fractionation companies seeking to enter or expand in Vietnam need market-specific data on demand patterns, competitive landscape, and regulatory requirements to develop localized commercial strategies.
      • Healthcare Investors & PE Firms : Investment firms evaluating opportunities in Vietnam's biopharmaceutical sector require detailed market analysis, growth projections, and risk assessments to make informed investment decisions.
      • Hospital & Healthcare Facility Operators : Vietnamese healthcare providers need market intelligence on plasma product availability, pricing trends, and clinical demand forecasts to optimize procurement and inventory management.
      • Distributors & Supply Chain Partners : Local and regional distributors require Vietnam-specific market data to identify growth opportunities, negotiate supplier agreements, and develop effective go-to-market strategies.
      • Government & Policy Makers : Vietnamese health authorities and policymakers need market insights to inform blood safety regulations, plasma collection policies, and healthcare resource allocation decisions.

      Reasons to Buy this Report

      • Vietnam-Specific Market Sizing : Obtain precise market valuation and forecasts tailored to Vietnam's unique healthcare landscape, enabling accurate budgeting and resource allocation for market entry or expansion strategies.
      • Competitive Positioning Intelligence : Understand Vietnam's competitive dynamics, key players, and market share distribution to identify partnership opportunities and differentiation strategies specific to the Vietnamese market.
      • Regulatory & Reimbursement Insights : Access detailed analysis of Vietnam's regulatory environment, pricing policies, and reimbursement mechanisms to navigate market entry barriers and optimize commercial strategies.
      • Growth Driver Analysis : Identify Vietnam-specific growth catalysts including healthcare infrastructure investments, disease prevalence trends, and demographic shifts driving plasma fractionation demand.
      • Distribution & Supply Chain Strategy : Leverage Vietnam-focused insights on distribution networks, cold chain capabilities, and logistics infrastructure to develop effective market penetration and supply chain optimization plans.

      Frequently asked questions

      What is the current size of Vietnam's plasma fractionation market?

      Vietnam's plasma fractionation market is estimated at USD 39.5 million in 2026 and is expected to grow to USD 49.5 million by 2031.

      What is the projected growth rate for plasma fractionation in Vietnam?

      Vietnam's plasma fractionation market is projected to grow at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2031.

      Which plasma-derived products are most in demand in Vietnam?

      Vietnam shows strong demand for immunoglobulins, clotting factors, and albumin, driven by increasing awareness of rare bleeding disorders and immunodeficiency conditions.

      What factors are driving growth in Vietnam's plasma fractionation market?

      Key growth drivers in Vietnam include strengthening healthcare infrastructure, government blood safety initiatives, rising healthcare expenditure, and growing patient populations requiring specialized plasma therapies.

      What opportunities exist for international companies in Vietnam's plasma market?

      International plasma manufacturers can establish regional distribution networks and manufacturing partnerships in Vietnam to capitalize on the expanding market through 2031.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global plasma fractionation market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size..

      Secondary Research

      The secondary sources for this research study include publications from government sources, such as FDA/CBER, EMA, WHO, and national health and regulatory authorities; industry associations, such as the Plasma Protein Therapeutics Association (PPTA), the International Plasma and Fractionation Association (IPFA), and AABB; and commercial databases, such as Bloomberg Business, D&B, Factiva, and relevant trade databases. Additional sources include white papers, annual reports, company house documents, investor presentations, scientific and clinical publications, regulatory filings, patent databases, and product and clinical trial databases. Secondary research was used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the plasma fractionation market. It was also used to obtain important information about key players, market classification, segmentation according to industry trends, the bottom-up approach, and key developments from market and technology perspectives. Secondary data was also used to assess plasma collection capacity, fractionation and manufacturing infrastructure, product portfolios, regulatory frameworks, trade patterns, clinical applications, and regional market trends. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market’s prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information.

      Plasma Fractionation Market
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the plasma fractionation market. These methods were also used extensively to estimate the size of various market segments.

      Plasma Fractionation Market : Top-Down and Bottom-Up Approach

      Plasma Fractionation Market Top Down and Bottom Up Approach

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Plasma-derived therapies are medical treatments based on human plasma. Plasma is the largest component of human blood and contains water, salts, enzymes, antibodies, and other proteins. Before it can be used in medical therapies, it undergoes a fractionation process in which the relevant proteins are separated. Plasma-derived therapies are used to treat a wide range of (rare) diseases, from bleeding disorders and inhibitor deficiencies to primary and secondary immunodeficiencies.

      Key Stakeholders

      • Plasma Fractionation Product Manufacturers and Distributors
      • Pharmaceutical and Biotechnology Companies
      • Healthcare Service Providers (including Hospitals and Clinics)
      • Research and Development (R&D) companies
      • Academic Institutes
      • Government Associations
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and forecast the plasma fractionation market based on product, application, therapeutic area, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall plasma fractionation market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the plasma fractionation market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the plasma fractionation market
      • To benchmark players within the plasma fractionation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Product Analysis

      • Further breakdown of the Rest of Europe Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Asia Pacific Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Latin America Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Middle East Plasma Fractionation Market, by country

      Company Information

      • Detailed analysis and profiling of additional market players (up to five)

      Get the Full Plasma Fractionation Market Report

      Full forecast, segment splits, and company analysis for all Plasma Fractionation Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status